Русский
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction
DOI: https://dx.doi.org/10.18565/urology.2019.6.146-149
A.A. Kaputovskij
Department of Urology and Andrology, IPPE of A.I. Burnazyan SSCFMBC of FMBA of Russia, Moscow, Russia
The lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) are an important medical and social problem. Combination of LUTS and ED is usually underdiagnosed. Selective phosphodiesterase 5 inhibitors (PDE5I) are recommended for treatment of both conditions. The aim of this review is to identify the best PDE5I for simultaneous treatment LUTS and ED.
Keywords: phosphodiesterase 5 inhibitors, efficacy, drug treatment, lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, safety
About the Autors
Corresponding author: A.A. Kaputovskij – Ph.D. student of the Department of Urology and Andrology, IPPE of A.I. Burnazyan SSCFMBC of FMBA of Russia, Moscow, Russia; e-mail: kaputovsky79@mail.ru
Similar Articles
